Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Pentavalent Rotavirus Vaccine in Healthy Infants
NCT05032391Phase 3Completed
- Sponsor
- Pharm Aid
- Start
- Feb 2019
- Primary completion
- Sep 2019
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Rotasil in rotavirus infection, sponsored by Pharm Aid. Started Feb 2019; status: completed.
02
Drugs
Rotasil
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT05032391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05032391.